Up to 15 million Americans suffer from age-related macular degeneration (AMD). It is the most common cause of severe vision loss, and it primarily impacts adults over the age of 60. Over 200,000 new cases are diagnosed each year, which fall into one of two forms – “wet” or neovascular, and “dry” or atrophic.
AMD affects central vision – that is the “straight ahead” vision needed to read, drive, watch TV, etc. There is no cure for this progressive disease, however, depending on the patients unique factors, there may be treatment options.
At Fichte, Endl & Elmer Eyecare, one of these treatment options is the newly FDA-approved telescopic lens implant. This implant refocuses light onto the remaining healthy area of the retina that has not been degenerated by the disease. After some post-operative therapy, patients experience improvement in their ability to see objects in the center of their field of vision.